What the Mount Raymond acquisition means for SLAM Exploration Ltd.’s Goodwin project scale (TSXV: SXL)
Read More 6 minute read Pharma Industry News Neuropathic corneal pain drug urcosimod receives FDA compassionate use authorization FDA authorizes compassionate use of urcosimod for neuropathic corneal pain. Discover what this changes for OKYO Pharma Limited and ophthalmology drug development. bySoujanya RaviJanuary 29, 2026